Therefore, hepassocin can be a relevant biomarker for analyzing risk states for diabetes and may be known by other names, such as fibrinogen-like protein 1 and hepatocyte-derived fibrinogen-related protein 1 (HFREP1) [18]. The gene discussed is FGL1; the disease is diabetes mellitus.